Blarcamesine from Anavex Shows Encouraging Results in Alzheimer’s Therapy
Anavex Life Sciences recently announced encouraging results from their phase 2b/3 clinical trial of blarcamesine (ANAVEX2-73), a promising investigational therapy for early Alzheimer’s…